Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,640,203
-$356,775 QoQ
Shares Held
109,643
+2.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#846
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argent Advisors, Inc. holds $22,940,677 across 9 Drug Manufacturers - General names. PFE ranks #5 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,391 | $5,266,697 | |
| 2 | JNJ |
Johnson & Johnson
|
20,074 | $5,098,193 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,547 | $3,154,289 | |
| 4 | GSK |
GSK plc
|
51,943 | $2,722,852 | |
| 5 | PFE |
Pfizer Inc
This page
|
109,643 | $2,640,203 | |
| 6 | AMGN |
Amgen Inc
|
4,586 | $1,660,682 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,701 | $1,478,304 | |
| 8 | ABBV |
AbbVie Inc.
|
2,592 | $652,250 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,640,203 | 109,643 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,996,978 | 106,730 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,499,885 | 100,397 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,785,906 | 109,337 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,521,420 | 104,019 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,480,355 | 97,883 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,307,048 | 86,960 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,869,053 | 99,138 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,550,013 | 91,137 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,235,345 | 80,553 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,930,024 | 67,038 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,285,612 | 68,906 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,326,905 | 63,438 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $2,464,483 | 60,404 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,912,071 | 56,832 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,486,705 | 56,826 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,885,589 | 55,037 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,724,965 | 52,636 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $3,541,110 | 59,968 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,478,623 | 57,629 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,945,194 | 49,673 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,679,441 | 46,355 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $1,556,584 | 42,287 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,531,195 | 41,722 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,321,244 | 40,405 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,248,576 | 38,253 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||